Financial Implications of Treating Breast Cancer with Standard Curative and Palliative Regimens Using the Cheapest and Costliest Branded Drugs: The First Drug Cost Analysis Study from India

Financial Implications of Treating Breast Cancer with Standard Curative and Palliative Regimens Using the Cheapest and Costliest Branded Drugs: The First Drug Cost Analysis Study from India

Introduction: In breast cancer care, chemotherapy is an important modality, and this study evaluated the cost-minimization analysis (CMA) considering the price of the most and the least expensive branded drugs by taking body surface area (BSA) relevant to the Indian context. Objectives: The objectiv...

Full description

Saved in:
Bibliographic Details
Main Authors: Abhishek Krishna, Nikku Mathew Geevarughese, Thomas George, Manjeshwar Poonam Baliga-Rao, Princy Louis Palatty, Manjeshwar Shrinath Baliga
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-04-01
Series:Journal of Radiation and Cancer Research
Subjects:
anticancer drugs
branded drugs
breast cancer
cost analysis
cost variance
indian market
pharmacoeconomics
Online Access:https://journals.lww.com/10.4103/jrcr.jrcr_24_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items